← Back
Data updated: Mar 10, 2026
SQUARE PHARMS
Pharmaceuticals
SQUARE PHARMS is a generic drug manufacturer with 3 FDA-approved products.
2018
Since
3
Drugs
-
Trials
59
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ARIPIPRAZOLE 2026-02-18
ACYCLOVIR 2026-01-22
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (0)
Company Info
- First Approval
- 2018-08-28
- Latest
- 2025-01-24
- Applications
- 3